All Posts Tagged With: "risk"
Increased Cancer Risk Associated with Treatment for Diabetic Leg and Foot Ulcers
The FDA is conducting a safety review based on study data suggesting there may be an increased risk of death from cancer in diabetic patients using Regranex (becaplermin) Gel, a skin product used to heal leg and foot ulcers. While the review is ongoing, the FDA recommends health care professionals discuss the potential risks and [...]
Popularity: 67% [?]
28Mar2008 | PharmaWatchDog | 2 comments | Continued
Graft use Associated with Increase Risk of Death
FDA issued a Public Health Notification to inform healthcare professionals of an update to earlier FDA safety information on this product. The notification re-emphasizes the need for continued surveillance of patients treated with endovascular grafts, and provides updated information on the mortality risks associated with the use of the AneuRx Stent Graft System to prevent [...]
Popularity: 58% [?]
20Mar2008 | PharmaWatchDog | 0 comments | Continued
Prezista causes Hepatitis
FDA and Tibotec Therapeutics notified healthcare professionals of changes to the WARNINGS section of the prescribing information for Prezista (darunavir) tablets regarding the risk of hepatotoxicity. In clinical trials and postmarketing experience, drug induced hepatitis has been reported in patients receiving combination therapy with Prezista/ritonavir. Appropriate laboratory testing should be conducted prior to initiating therapy [...]
Popularity: 50% [?]
12Mar2008 | PharmaWatchDog | 0 comments | Continued
